Myocardial fibrosis and ventricular remodeling in severe chronic aortic regurgitation

Nelson Elias1, Flávio Tarasoutchi, Guilherme Sobreira Spina

  • 1Instituto do Coração, Hospital das Clínicas, Faculdade de Medicina, Universidade de São Paulo, São Paulo, SP, Brazil.

Insights

In patients with chronic severe aortic regurgitation, myocardial fibrosis was elevated but did not correlate with clinical outcomes or left ventricular remodeling. This suggests limited fibrosis may not impact complications in these patients.

Area of Science:

  • Cardiology
  • Cardiovascular Pathology
  • Cardiac Surgery

Background:

  • Symptomatic chronic aortic regurgitation (AR) causes significant left ventricular (LV) remodeling.
  • The role of interstitial fibrosis in AR pathophysiology is not well understood.

Purpose of the Study:

  • To evaluate the extent of myocardial fibrosis in patients with chronic severe aortic regurgitation.

Main Methods:

  • Twenty-eight symptomatic AR patients underwent echocardiography and cardiopulmonary testing.
  • Myocardial fibrosis volume fraction (MFV) was quantified via endomyocardial biopsy during surgery.
  • Histopathology was compared to a nine-patient control group.

Main Results:

  • Patients with AR showed significantly higher MFV compared to controls (3.47% vs 0.82%, p=0.001).
  • No correlation was found between LV fibrosis and LV dimensions, ejection fraction, or maximal oxygen consumption.
  • LV diameters significantly reduced post-surgery; functional capacity remained similar.

Conclusions:

  • Limited myocardial fibrosis in significant symptomatic AR is not associated with clinical, echocardiographic, or functional complications.
  • Further research may clarify the prognostic significance of varying fibrosis levels in AR.
Abstract

Related Concept Videos

Aortic Regurgitation I: Introduction01:15

Aortic Regurgitation I: Introduction

IntroductionAortic regurgitation is characterized by the backward flow of blood from the aorta into the left ventricle during diastole and arises from the improper closure of the aortic valve. This condition results in left ventricular volume overload and can stem from both acute and chronic etiologies, each contributing uniquely to the disease's progression and symptomatology.Acute and Chronic CausesAcute aortic regurgitation often results from events that suddenly impair the integrity of the...
Aortic Regurgitation II: Clinical Features and Diagnostic Tests01:22

Aortic Regurgitation II: Clinical Features and Diagnostic Tests

Aortic valve regurgitation (AR) occurs when the aortic valve fails to close properly, allowing blood to flow backward from the aorta into the left ventricle. This backflow can result in two distinct clinical presentations: acute and chronic AR, each characterized by its own set of symptoms and physical findings.Acute Aortic RegurgitationAcute AR presents with a sudden onset of severe symptoms. Patients typically experience profound dyspnea (shortness of breath), chest pain, and signs of left...
Aortic Regurgitation III: Medical Management01:25

Aortic Regurgitation III: Medical Management

Aortic regurgitation (AR) is when the aortic valve does not close or seal properly, leading to backward blood circulation from the aorta into the left ventricle during diastole. Common causes of AR include rheumatic heart disease, congenital valve defects, and aortic root dilation. Managing AR requires a multifaceted approach to alleviate symptoms, preserve left ventricular function, and address the underlying cause of the regurgitation. Patients with symptomatic AR or significant left...
Heart Failure II: Pathophysiology01:29

Heart Failure II: Pathophysiology

Systolic Heart Failure and Compensatory MechanismsSystolic heart failure (also termed HFrEF, Heart Failure with Reduced Ejection Fraction) is the most prevalent type of heart filure. It results in a decreased volume of blood being pumped from the ventricle. The aortic arch and carotid sinuses have baroreceptors that detect reduced blood pressure, triggering the sympathetic nervous system (SNS) to release epinephrine and norepinephrine. Initially, this response aims to boost heart rate and...
Mitral Regurgitation I: Introduction01:20

Mitral Regurgitation I: Introduction

Mitral regurgitation is characterized by the backward circulation of blood from the left ventricle to the left atrium during systole, a phase of the cardiac cycle when the heart contracts and pumps blood out of the chambers. This abnormal flow occurs primarily due to the dysfunction of the mitral valve or its supporting structures, which include the mitral leaflets, chordae tendineae, annulus, and papillary muscles.Etiology and Mechanisms:Primary Mitral Regurgitation: This type arises from...
Rheumatic Heart Disease I: Introduction01:23

Rheumatic Heart Disease I: Introduction

Rheumatic heart disease or RHD is a chronic condition that results from rheumatic fever, causing permanent damage to the heart valves.Etiology and Risk FactorsIt primarily arises from rheumatic fever, an inflammatory disease that can develop after untreated or inadequately treated group A streptococcal (GAS) pharyngitis. Streptococcus spreads through direct contact with oral or respiratory secretions. While the bacteria are the causative agents, factors like malnutrition, overcrowding, poor...